Penumbra, Inc. (PEN)
Company Info
| ISIN | US70975L1070 |
|---|---|
| CUSIP | 70975L107 |
| Sector | Healthcare |
| Industry | Medical Devices |
| IPO Date | Sep 18, 2015 |
Highlights
| Market Cap | $9.07B |
|---|---|
| EPS (TTM) | $0.87 |
| PE Ratio | 271.52 |
| PEG Ratio | -62.27 |
| Total Revenue (TTM) | $1.16B |
| Gross Profit (TTM) | $726.29M |
| EBITDA (TTM) | $99.20M |
| Year Range | $148.00 - $277.34 |
| Target Price | $234.12 |
| Short % | 8.32% |
| Short Ratio | 6.26 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: PEN vs. ELF, PEN vs. MEDP, PEN vs. PODD, PEN vs. VOO, PEN vs. SPY, PEN vs. LLY
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Penumbra, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Penumbra, Inc. had a return of -6.09% year-to-date (YTD) and 13.13% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -6.09% | 25.48% |
| 1 month | 16.26% | 2.14% |
| 6 months | 13.17% | 12.76% |
| 1 year | 13.13% | 33.14% |
| 5 years (annualized) | 7.49% | 13.96% |
| 10 years (annualized) | N/A | 11.39% |
Monthly Returns
The table below presents the monthly returns of PEN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 0.26% | -6.85% | -5.00% | -11.97% | -3.56% | -5.01% | -7.16% | 21.08% | -3.96% | 17.79% | -6.09% | ||
| 2023 | 12.56% | 3.83% | 7.19% | 1.95% | 8.17% | 11.95% | -11.83% | -12.81% | -8.54% | -20.98% | 16.19% | 13.26% | 13.07% |
| 2022 | -21.34% | -1.89% | 0.18% | -22.32% | -14.86% | -15.25% | 11.93% | 17.79% | 15.49% | -9.56% | 22.18% | 6.18% | -22.57% |
| 2021 | 49.19% | 8.94% | -4.87% | 13.09% | -18.59% | 10.02% | -2.86% | 3.28% | -3.07% | 3.77% | -11.17% | 16.96% | 64.18% |
| 2020 | 6.81% | -5.47% | -2.73% | 9.91% | -2.76% | 3.71% | 24.10% | -5.75% | -7.06% | 34.29% | -14.99% | -21.14% | 6.53% |
| 2019 | 19.08% | -8.14% | 9.98% | -8.51% | 6.10% | 12.12% | 4.75% | -13.16% | -7.60% | 15.97% | 13.43% | -7.15% | 34.43% |
| 2018 | 5.84% | 8.63% | 6.89% | 7.52% | 29.39% | -14.14% | 2.97% | -2.39% | 7.81% | -9.15% | 2.37% | -12.23% | 29.86% |
| 2017 | 12.15% | 7.34% | 8.66% | 2.40% | -3.04% | 5.91% | -6.95% | 5.33% | 5.00% | 11.35% | 4.72% | -10.64% | 47.49% |
| 2016 | -20.46% | 8.93% | -1.33% | 18.48% | -3.14% | 12.71% | 14.81% | 3.29% | 7.70% | -13.21% | -6.14% | 3.07% | 18.57% |
| 2015 | -2.91% | -7.66% | 35.89% | 6.94% | 30.29% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of PEN is 58, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Penumbra, Inc. (PEN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Penumbra, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Penumbra, Inc. was 62.64%, occurring on Jun 16, 2022. Recovery took 224 trading sessions.
The current Penumbra, Inc. drawdown is 31.34%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -62.64% | Apr 29, 2021 | 287 | Jun 16, 2022 | 224 | May 9, 2023 | 511 |
| -52.44% | Jul 3, 2023 | 277 | Aug 7, 2024 | — | — | — |
| -35.86% | Nov 13, 2020 | 23 | Dec 16, 2020 | 36 | Feb 9, 2021 | 59 |
| -35.83% | Feb 20, 2020 | 23 | Mar 23, 2020 | 74 | Jul 8, 2020 | 97 |
| -31.65% | Jun 7, 2018 | 139 | Dec 24, 2018 | 118 | Jun 14, 2019 | 257 |
Volatility
Volatility Chart
The current Penumbra, Inc. volatility is 10.59%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Valuation
The Valuation section provides an assessment of the market value of Penumbra, Inc. compared to its peers in the Medical Devices industry.
PE Ratio
The chart displays the price to earnings (P/E) ratio for PEN in comparison to other companies of the Medical Devices industry. Currently, PEN has a PE value of 271.5. This PE ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.PEG Ratio
The chart displays the price to earnings to growth (PEG) ratio for PEN in comparison to other companies of the Medical Devices industry. Currently, PEN has a PEG value of -62.3. This PEG value is considered to be low compared to the rest of the industry.Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Penumbra, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |